Document Detail


A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium.
MedLine Citation:
PMID:  20350698     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Alterations of endothelial nitric oxide synthase (eNOS) enzyme activity via eNOS gene polymorphisms have been associated with significant cardiovascular morbidity and mortality. Both the thymidine to cytosine transition mutation (T(-786)-->C) in the promoter region and the missense mutation in the exon 7 coding region of the eNOS gene (G(894)-->T) have been associated with several cardiovascular disease states. We hypothesized that heart transplant recipients who carried at least 1 allele of either of the polymorphisms would have reduced myocardial tissue expression of eNOS measured in the explanted heart.
METHODS AND RESULTS: Genomic DNA was isolated from myocardial tissue samples obtained from 43 explanted human hearts using standard methods. Regions of the eNOS gene were amplified from genomic DNA with a polymerase chain reaction using specific primers. Protein expression of eNOS was measured by Western blot analysis. There was a statistically significant decrease in mean eNOS expression in samples containing at least one allele for the T(-786)-->C promoter polymorphism (P=.04) compared with patients homozygous for the T allele. There was no change in eNOS expression associated with the G(894)-->T exonic polymorphisms.
CONCLUSIONS: Our data show in failing human myocardium that the T(-786)-->C promoter polymorphism is associated with reduced eNOS expression, whereas the G(894)-->T polymorphism of exon 7 is not associated with change in either eNOS mRNA or protein expression. Reduced eNOS expression associated with the promoter polymorphism may contribute to the vascular, contractile, and autonomic responses to ventricular failure.
Authors:
Amit A Doshi; Mark T Ziolo; Honglan Wang; Emily Burke; Amanda Lesinski; Philip Binkley
Related Documents :
18997828 - The polymorphism il-1beta t-31c is associated with a longer overall survival in patient...
20017708 - Association of interleukin-18 gene polymorphisms with calcium oxalate kidney stone dise...
20030788 - Polymorphisms of cytotoxic t lymphocyte-associated antigen-4 and cytokine genes in taiw...
22447748 - Genetic testing for autism spectrum disorders.
21493958 - The genetics of panic disorder.
4024898 - Detection of normal-hearing carriers of the gene for the autosomal dominant progressive...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2010-02-07
Journal Detail:
Title:  Journal of cardiac failure     Volume:  16     ISSN:  1532-8414     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-30     Completed Date:  2010-10-29     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  314-9     Citation Subset:  IM    
Copyright Information:
(c) 2010 Elsevier Inc. All rights reserved.
Affiliation:
Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH 43210, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cytosine Nucleotides / genetics
Down-Regulation / genetics
Female
Gene Expression Regulation
Heart Failure / enzymology*,  genetics*,  pathology
Humans
Male
Middle Aged
Myocardium / enzymology*,  pathology*
Nitric Oxide Synthase Type III / antagonists & inhibitors,  biosynthesis,  genetics*
Polymorphism, Single Nucleotide / genetics*
Promoter Regions, Genetic / genetics*
RNA, Messenger / antagonists & inhibitors,  biosynthesis,  genetics*
Thymine Nucleotides / genetics
Grant Support
ID/Acronym/Agency:
K24 EB002637-04/EB/NIBIB NIH HHS; K24 EB002637-05/EB/NIBIB NIH HHS; K24 HL004208-01/HL/NHLBI NIH HHS; K24 HL004208-02/HL/NHLBI NIH HHS; K24 HL004208-03/HL/NHLBI NIH HHS; R01 HL079283-01A1/HL/NHLBI NIH HHS; R01 HL079283-02/HL/NHLBI NIH HHS; R01 HL079283-03/HL/NHLBI NIH HHS; R01 HL079283-04/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Cytosine Nucleotides; 0/RNA, Messenger; 0/Thymine Nucleotides; EC 1.14.13.39/Nitric Oxide Synthase Type III
Comments/Corrections
Comment In:
J Card Fail. 2010 Jul;16(7):618; author reply 618-9   [PMID:  20610239 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum Midkine as a Predictor of Cardiac Events in Patients With Chronic Heart Failure.
Next Document:  Concordant Versus Discordant Left Bundle Branch Block in Heart Failure Patients: Novel Clinical Valu...